 |
0 Diseases |  |
0 Trials |
|
0 Trials |  |
2 News |  |
- | ALT-P1 (somatropin biosimilar) / Alteogen, Korea Kolmar
Trial completion, Trial initiation date: Safety, Tolerability, PK, PD, ADA of Escalating Single Dose of CJ-40002 in Healthy Male Subjects (clinicaltrials.gov) - Dec 29, 2016
P1, N=40, Completed, Sponsor: CJ HealthCare Corporation
Not yet recruiting --> Completed | Initiation date: Jun 2014 --> Nov 2014
- ALT-P1 (somatropin biosimilar) / Alteogen, Korea Kolmar
New P1 trial: Safety, Tolerability, PK, PD, ADA of Escalating Single Dose of CJ-40002 in Healthy Male Subjects (clinicaltrials.gov) - May 22, 2014
P1, N=40, Not yet recruiting, Sponsor: CJ HealthCare Corporation